Impairment of regulatory T cell stability in axial spondyloarthritis: role of EZH2 and pSTAT5FRONTIERS IN IMMUNOLOGYIF5.92024-11-060OAAI
Red blood cell metabolomics identify ergothioneine as a key metabolite in DMARD-naïve rheumatoid arthritis and response to methotrexateSCIENTIFIC REPORTSIF3.92024-09-091OAAI
Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus ErythematosusFRONTIERS IN IMMUNOLOGYIF5.92021-05-0312OAAI
Deoxyribonuclease 1-Mediated Clearance of Circulating Chromatin Prevents From Immune Cell Activation and Pro-inflammatory Cytokine Production, a Phenomenon Amplified by Low Trap1 Activity: Consequences for Systemic Lupus ErythematosusFRONTIERS IN IMMUNOLOGYIF5.92021-03-0411OAAI
Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid ArthritisARTHRITIS & RHEUMATOLOGYIF10.92020-02-2028PREAI
In vitro activity of Cacicol® on herpes simplex virus type 1: a promising adjunct therapy of herpetic corneal infections?ACTA OPHTHALMOLOGICAIF2.82016-09-140OA
Carabin Protects Against Cardiac Hypertrophy by Blocking Calcineurin, Ras, and Ca2+/Calmodulin-Dependent Protein Kinase II SignalingCIRCULATIONIF38.62015-01-2744OAAI
Rap-linked cAMP signaling Epac proteins: Compartmentation, functioning and disease implicationsCELLULAR SIGNALLINGIF3.72011-08-01116PREAI
Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathwayCELLULAR SIGNALLINGIF3.72010-10-0161PREAI